City of Jenks v. Purdue Pharma L.P. et al
City of Jenks |
Walgreens Boots Alliance, Inc., Insys Therapeutic, Inc., Anda, Inc., Purdue Pharma L.P., Mallinckrodt LLC, Anda Pharmaceuticals, Inc., Morris & Dickson Co, LLC, Mallinckrodt PLC, Teva Pharmaceutical Industries, Ltd., Allergan PLC, Teva Pharmaceuticals USA, Inc., Keysource Medical, Inc., Endo Pharmaceuticals Inc., Actavis LLC, Cardinal Health, Inc., Quest Pharmaceuticals, Inc., Harvard Drug Group, LLC, The, Actavis Pharma, Inc., Watson Laboratories, Inc., Walgreen Co., Cephalon, Inc., Activas PLC, Endo Health Solutions Inc., Johnson & Johnson, Watson Pharmaceuticals, Inc., Purdue Pharma Inc., McKesson Corp., AmerisourceBergen Drug Corporation, Janssen Pharmaceuticals, Inc., CVS Health Corporation, Watson Pharma, Inc., Physicians Total Care, Inc., Oklahoma CVS Pharmacy, LLC, GCP Pharma, LLC, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica, Inc., Purdue Frederick Company, Inc., The and CVS Pharmacy, Inc. |
4:2019cv00380 |
July 11, 2019 |
US District Court for the Northern District of Oklahoma |
Gregory K Frizzell |
Frank H McCarthy |
P.I.: Other |
28 U.S.C. § 1332 |
Plaintiff |
Docket Report
This docket was last retrieved on August 30, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 62 RESPONSE in Opposition to Motion (Re: #50 MOTION to Remand and Brief in Support ) by McKesson Corp. ; (With attachments) (Campbell, Stuart) |
Filing 61 RESPONSE in Opposition to Motion (Re: #50 MOTION to Remand and Brief in Support ) by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. ; (Zschiesche, Raymond) |
Filing 60 ORDER by Judge Gregory K Frizzell ; staying case; granting #55 Motion to Stay (kjp, Dpty Clk) |
Filing 59 Joint REPLY to Response to Motion (Re: #55 Joint MOTION to Stay Proceedings Pending Likely Transfer to Multidistrict Litigation ) by AmerisourceBergen Drug Corporation, Cardinal Health, Inc., McKesson Corp. ; (Campbell, Stuart) Modified on 8/29/2019 to change text to reflect correct event (sac, Dpty Clk). |
Filing 58 RESPONSE in Opposition to Motion (Re: #55 Joint MOTION to Stay Proceedings Pending Likely Transfer to Multidistrict Litigation ) by City of Jenks ; (With attachments) (Court, Todd) |
Filing 57 MINUTE ORDER by Judge Gregory K Frizzell Response deadline to the Joint Motion to Stay Proceedings [Doc. 55] is due by August 26, 2019. A Reply, limited to 5 pages, is due by August 28, 2019., setting/resetting deadline(s)/hearing(s): ( Responses due by 8/26/2019, Replies due by 8/28/2019) (Re: #55 Joint MOTION to Stay Proceedings Pending Likely Transfer to Multidistrict Litigation ) (This entry is the Official Order of the Court. No document is attached.) (kjp, Dpty Clk) |
Filing 56 RESPONSE in Opposition to Motion (Re: #51 MOTION to Expedite Ruling - Plaintiff's Motion for Expedited Treatment of Motion to Remand ) by McKesson Corp. ; (Campbell, Stuart) |
Filing 55 Joint MOTION to Stay Proceedings Pending Likely Transfer to Multidistrict Litigation by McKesson Corp. (Campbell, Stuart) |
Filing 54 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent CVS Pharmacy, Inc. for Oklahoma CVS Pharmacy, LLC) by Oklahoma CVS Pharmacy, LLC (Sharpe, G) |
Filing 53 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent CVS Health Corporation for CVS Pharmacy, Inc.) by CVS Pharmacy, Inc. (Sharpe, G) |
Filing 52 CORPORATE DISCLOSURE STATEMENT by CVS Health Corporation (Sharpe, G) |
Filing 51 MOTION to Expedite Ruling - Plaintiff's Motion for Expedited Treatment of Motion to Remand (Re: #50 MOTION to Remand and Brief in Support ) by City of Jenks (With attachments) (kjp, Dpty Clk) |
Filing 50 MOTION to Remand and Brief in Support by City of Jenks (With attachments) (kjp, Dpty Clk) |
Filing 49 MINUTE ORDER by Court Clerk , directing Purdue Pharma L.P, Purdue Pharma Inc., Purdue Frederick Company, Inc., The, CVS Health Corporation, CVS Pharmacy, Inc. and Oklahoma CVS Pharmacy, LLC to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) |
Filing 48 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Pharmaceutical Research Associates, Inc. for Purdue Frederick Company, Inc., The) by Purdue Frederick Company, Inc., The (Coats, Sanford) |
Filing 47 CORPORATE DISCLOSURE STATEMENT by Purdue Pharma Inc. (Coats, Sanford) |
Filing 46 CORPORATE DISCLOSURE STATEMENT (identifying: Other Affiliate Purdue Pharma Inc., Other Affiliate Pharmaceutical Research Associates L.P. for Purdue Pharma L.P.) by Purdue Pharma L.P. (Coats, Sanford) |
Filing 45 ORDER by Judge Gregory K Frizzell ; granting #44 Motion for Extension of Time to Answer (kjp, Dpty Clk) |
Filing 44 Unopposed MOTION for Extension of Time to Answer Move or Otherwise Respond to Petition Under Rule 12 (Re: State Court Petition/Complaint ) by CVS Health Corporation, CVS Pharmacy, Inc., Oklahoma CVS Pharmacy, LLC, Walgreens Boots Alliance, Inc. [Note: Attorney G Calvin Sharpe added to party CVS Health Corporation(pty:dft), Attorney G Calvin Sharpe added to party CVS Pharmacy, Inc.(pty:dft), Attorney G Calvin Sharpe added to party Oklahoma CVS Pharmacy, LLC(pty:dft), Attorney G Calvin Sharpe added to party Walgreens Boots Alliance, Inc.(pty:dft).] (Sharpe, G) |
Filing 43 ATTORNEY APPEARANCE by Sanford C Coats on behalf of Purdue Frederick Company, Inc., The, Purdue Pharma Inc., Purdue Pharma L.P. [Note: Attorney Sanford C Coats added to party Purdue Frederick Company, Inc., The(pty:dft), Attorney Sanford C Coats added to party Purdue Pharma Inc.(pty:dft), Attorney Sanford C Coats added to party Purdue Pharma L.P.(pty:dft).] (Coats, Sanford) |
Filing 42 MINUTE ORDER by Court Clerk , directing Quest Pharmaceuticals, Inc. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (dlg, Dpty Clk) |
Filing 41 ORDER by Judge Gregory K Frizzell ; granting #39 Motion for Extension of Time to Answer (kjp, Dpty Clk) |
Filing 40 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Quest Pharmaceuticals, Inc. for Quest Pharmaceuticals, Inc.) by Quest Pharmaceuticals, Inc. (Riddles, D) |
Filing 39 Unopposed MOTION for Extension of Time to Answer , Move or Otherwise Respond to Petition Under Rule 12 (Re: State Court Petition/Complaint ) by Quest Pharmaceuticals, Inc. (Riddles, D) |
Filing 38 ATTORNEY APPEARANCE by D Todd Riddles on behalf of Quest Pharmaceuticals, Inc. [Note: Attorney D Todd Riddles added to party Quest Pharmaceuticals, Inc.(pty:dft).] (Riddles, D) |
Filing 37 MINUTE ORDER by Judge Gregory K Frizzell ; granting #36 Motion for Extension of Time to Answer (This entry is the Official Order of the Court. No document is attached.) (lah, Chambers) |
Filing 36 Unopposed MOTION for Extension of Time to Answer Move or Otherwise Respond to Petition Under Rule 12 (Re: State Court Petition/Complaint ) by AmerisourceBergen Drug Corporation, Cardinal Health, Inc., Harvard Drug Group, LLC, The, McKesson Corp. (Campbell, Stuart) |
NOTICE of Docket Entry Modification; Error: wrong event selected (Notice - Other); Correction: changed text to reflect correct event (Notice of Removal - Amended) (Re: #35 Notice (Other) ) (sac-qc, Dpty Clk) |
Filing 35 Amended NOTICE of Removal by McKesson Corp. (With attachments) (Campbell, Stuart) Modified on 7/24/2019 to change text to reflect correct event (sac-qc, Dpty Clk). |
MINUTE ORDER by Court Clerk , directing Cephalon, Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc., Actavis Pharma, Inc. and Actavis LLC to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) |
NOTICE of Docket Entry Modification; Error: filers selected in error; Correction: removed filers selected in error (Re: #34 Appearance - Attorney,, ) (sac-qc, Dpty Clk) |
Filing 34 ATTORNEY APPEARANCE by Robert Garner McCampbell on behalf of Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. [Note: Attorney Robert Garner McCampbell added to party Actavis LLC(pty:dft), Attorney Robert Garner McCampbell added to party Actavis Pharma, Inc.(pty:dft), Attorney Robert Garner McCampbell added to party Cephalon, Inc.(pty:dft), Attorney Robert Garner McCampbell added to party Teva Pharmaceuticals USA, Inc.(pty:dft), Attorney Robert Garner McCampbell added to party Watson Laboratories, Inc.(pty:dft).] (McCampbell, Robert) Modified on 7/19/2019 to remove filers selected in error (sac-qc, Dpty Clk). |
Filing 33 MINUTE ORDER by Court Clerk , directing Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica, Inc. and Watson Pharmaceuticals, Inc. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) |
Filing 32 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent TEVA Pharmaceuticals Industries, LTD for Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc.) by Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (Merkley, Nicholas) |
Filing 31 ATTORNEY APPEARANCE by Nicholas Vernon Merkley on behalf of Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. [Note: Attorney Nicholas Vernon Merkley added to party Actavis LLC(pty:dft), Attorney Nicholas Vernon Merkley added to party Actavis Pharma, Inc.(pty:dft), Attorney Nicholas Vernon Merkley added to party Cephalon, Inc.(pty:dft), Attorney Nicholas Vernon Merkley added to party Teva Pharmaceuticals USA, Inc.(pty:dft), Attorney Nicholas Vernon Merkley added to party Watson Laboratories, Inc.(pty:dft).] (Merkley, Nicholas) |
Filing 30 ATTORNEY APPEARANCE by Elizabeth Anne Price on behalf of Watson Pharmaceuticals, Inc. [Note: Attorney Elizabeth Anne Price added to party Watson Pharmaceuticals, Inc.(pty:dft).] (Price, Elizabeth) |
Filing 29 ATTORNEY APPEARANCE by William A Johnson on behalf of Watson Pharmaceuticals, Inc. (Johnson, William) |
Filing 28 MINUTE ORDER by Court Clerk , directing Anda Pharmaceuticals, Inc., Anda, Inc. and McKesson Corp. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) |
Filing 27 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Johnson & Johnson for Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc.) by Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (Ridgeway, Michael) |
Filing 26 ATTORNEY APPEARANCE by Michael W Ridgeway on behalf of Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. [Note: Attorney Michael W Ridgeway added to party Janssen Pharmaceutica, Inc.(pty:dft), Attorney Michael W Ridgeway added to party Janssen Pharmaceuticals, Inc.(pty:dft), Attorney Michael W Ridgeway added to party Johnson & Johnson(pty:dft), Attorney Michael W Ridgeway added to party Ortho-McNeil-Janssen Pharmaceuticals, Inc.(pty:dft).] (Ridgeway, Michael) |
Filing 25 ATTORNEY APPEARANCE by John Hunt Sparks on behalf of Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. [Note: Attorney John Hunt Sparks added to party Janssen Pharmaceutica, Inc.(pty:dft), Attorney John Hunt Sparks added to party Janssen Pharmaceuticals, Inc.(pty:dft), Attorney John Hunt Sparks added to party Johnson & Johnson(pty:dft), Attorney John Hunt Sparks added to party Ortho-McNeil-Janssen Pharmaceuticals, Inc.(pty:dft).] (Sparks, John) |
Filing 24 ORDER by Judge Gregory K Frizzell ; granting #23 Motion for Extension of Time to Answer (kjp, Dpty Clk) |
Filing 23 Unopposed MOTION for Extension of Time to Answer or File Responsive Pleadings (Re: State Court Petition/Complaint ) by Watson Pharmaceuticals, Inc. [Note: Attorney William A Johnson added to party Watson Pharmaceuticals, Inc.(pty:dft).] (Johnson, William) |
Filing 22 MINUTE ORDER by Judge Gregory K Frizzell Granting Unopposed Joint Motion to Extend Time to Answer, Move, or Otherwise Respond to Petition Under Rule 12 [Doc. 18]. Anda Defendants shall answer, move, or otherwise respond to Plaintiffs Complaint within forty-five (45) days after the later of an entry of: 1) a decision by the JPML granting a motion to vacate a conditional transfer order covering this action or otherwise finally denying transfer of this action, or 2) this Courts ruling on any motion to remand this action. ; granting #18 Motion for Extension of Time to Answer (This entry is the Official Order of the Court. No document is attached.) (kjp, Dpty Clk) |
Filing 21 CORPORATE DISCLOSURE STATEMENT by McKesson Corp. (Campbell, Stuart) |
Filing 20 ATTORNEY APPEARANCE by Stuart Douglas Campbell on behalf of McKesson Corp. (Campbell, Stuart) |
Filing 19 ATTORNEY APPEARANCE by Jeffrey Allen Curran on behalf of Anda Pharmaceuticals, Inc., Anda, Inc. [Note: Attorney Jeffrey Allen Curran added to party Anda Pharmaceuticals, Inc.(pty:dft), Attorney Jeffrey Allen Curran added to party Anda, Inc.(pty:dft).] (Curran, Jeffrey) |
Filing 18 Unopposed MOTION for Extension of Time to Answer (Re: State Court Petition/Complaint ) by Anda Pharmaceuticals, Inc., Anda, Inc. (Quinn, Ashley) |
Filing 17 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent TEVA Pharmaceuticals Industries, LTD for Anda Pharmaceuticals, Inc., Anda, Inc.) by Anda Pharmaceuticals, Inc., Anda, Inc. (Quinn, Ashley) |
Filing 16 ATTORNEY APPEARANCE by Ashley E Quinn on behalf of Anda Pharmaceuticals, Inc., Anda, Inc. [Note: Attorney Ashley E Quinn added to party Anda Pharmaceuticals, Inc.(pty:dft), Attorney Ashley E Quinn added to party Anda, Inc.(pty:dft).] (Quinn, Ashley) |
Filing 15 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Cardinal Health, Inc., Corporate Parent Generic Drug Holdings, Inc., Corporate Parent HDG Acquisition, Inc., Corporate Parent Cardinal Health 110, LLC for Harvard Drug Group, LLC, The) by Harvard Drug Group, LLC, The (Ray, Ryan) |
Filing 14 CORPORATE DISCLOSURE STATEMENT by Cardinal Health, Inc. (Ray, Ryan) |
Filing 13 ATTORNEY APPEARANCE by Ryan A Ray on behalf of Harvard Drug Group, LLC, The (Ray, Ryan) |
Filing 12 ATTORNEY APPEARANCE by Ryan A Ray on behalf of Cardinal Health, Inc. (Ray, Ryan) |
Filing 11 ATTORNEY APPEARANCE by D Michael McBride, III on behalf of AmerisourceBergen Drug Corporation (McBride, D) |
Filing 10 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent AmerisourceBergen Corporation, Corporate Parent AmerisourceBergen Services Corporation for AmerisourceBergen Drug Corporation) by AmerisourceBergen Drug Corporation (Huntsman, Susan) |
Filing 9 ATTORNEY APPEARANCE by Susan E Huntsman on behalf of AmerisourceBergen Drug Corporation (Huntsman, Susan) |
Filing 8 STATUS REPORT on Removed Action by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Zschiesche, Raymond) |
Filing 7 MINUTE ORDER by Court clerk randomly reassigning case due to attorney conflict, recusing Chief Judge John E Dowdell. Judge Gregory K Frizzell reassigned to case., changing case number to 19-CV-380-GKF-FHM (This entry is the Official Order of the Court. No document is attached.) (lml, Dpty Clk) |
Filing 6 MINUTE ORDER by Court Clerk , directing Endo Health Solutions Inc., Endo Pharmaceuticals Inc., McKesson Corp., Cardinal Health, Inc., AmerisourceBergen Corp. and Harvard Drug Group, LLC, The to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) |
Filing 5 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Endo International plc for Endo Health Solutions Inc.) by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Zschiesche, Raymond) |
Filing 4 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Endo International plc for Endo Pharmaceuticals Inc.) by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Zschiesche, Raymond) |
Filing 3 ATTORNEY APPEARANCE by Raymond Edward Zschiesche on behalf of Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Zschiesche, Raymond) |
Filing 2 NOTICE of Removal from District Court of Tulsa County, Oklahoma, case number CJ-2019-02431 (paid $400 filing fee; receipt number 1085-2077419) by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (With attachments) (Zschiesche, Raymond) |
Filing 1 CIVIL COVER SHEET by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Zschiesche, Raymond) |
PETITION/COMPLAINT with Jury Demand filed in State Court against All Defendants by City of Jenks (jln, Dpty Clk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Oklahoma Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.